NCT07172568 Blood Flow Restriction Training For The Treatment Of Lateral Epicondylopathy
| NCT ID | NCT07172568 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Technical University of Munich |
| Condition | Elbow Tendinopathy |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2021-08-25 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2021-08-25 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study aims to evaluate the effectiveness of Blood Flow Restriction Training for the treatment of lateral elbow epicondylopathy.
Eligibility Criteria
Inclusion Criteria: * diagnosis of lateral epicondylitis * duration of symptoms \> 6 weeks * failed physical therapy * absence of x-ray abnormalities * written and informed consent Exclusion Criteria: * prior joint infiltrations * duration of symptoms \> 12 months * concomitant rheumatoid diseases * concomitant elbow pathologies, including medial epicondylitis * concomitant radicular symptoms of the cervical spine, shoulder or hand * traumatic etiology of symptoms
Contact & Investigator
Maximilian Hinz, MD
PRINCIPAL INVESTIGATOR
Department of Sports Orthopaedics, Technical University of Munich
Frequently Asked Questions
Who can join the NCT07172568 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Elbow Tendinopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07172568 currently recruiting?
Yes, NCT07172568 is actively recruiting participants. Contact the research team at a.doucas@tum.de for enrollment information.
Where is the NCT07172568 trial being conducted?
This trial is being conducted at Munich, Germany.
Who is sponsoring the NCT07172568 clinical trial?
NCT07172568 is sponsored by Technical University of Munich. The principal investigator is Maximilian Hinz, MD at Department of Sports Orthopaedics, Technical University of Munich. The trial plans to enroll 40 participants.